Dear Colleague,
welcome to the new NAFLD Group website.

Below are our upcoming events.

Mark your calendars!

NAFLD STUDY GROUP VIRTUAL MEETING & ABSTRACTS SESSION with award 23-24 October, 2023

Dear Colleague,

The 2023 NAFLD Study Group annual webinar is scheduled via Zoom on Monday, October 23, and Tuesday, October 24, from 3:00 p.m. to 7:00 p.m. Every year, our study group brings together clinicians and senior and young researchers with invited presentations from key opinion leaders on MASLD, pathophysiological mechanisms, novel findings in diagnostic biomarkers and therapeutic targets.

In the first hour of each day, we will have a selection of abstracts from young researchers on the topic of MASLD ( download submission form ).
The deadline for submission is October 16. The best abstract will receive a 500 euro award sponsored by Lilly®.

We've attached a preliminary program
You can register for the webinar via this link:
https://us02web.zoom.us/webinar/register/WN__X7OIy8YRP6WNlizy78J5A
Please note that only pre-registered individuals can join, and registration is free.
Please feel free to share this announcement with your colleagues and students and encourage them to contact us to be included in the mailing list.

If you have any questions, please don't hesitate to contact us.
We look forward to your participation.

The EASD Annual Meeting will be a hybrid event, providing the option to join in person in Hamburg, Germany or online via the Virtual Meeting platform.

NAFLD SYMPOSIUM at EASD
Tuesday, October 3, 2023 at 1:30 PM CEST, Chicago Hall

Chairs: Paula Macedo, Catherine Postic
‍
Opening A. Gastaldelli
Cardiometabolic Risk Lab., Institute of Clinical Physiology, CNR, Pisa, Italy.
1:30PM-1:35 PM - 5m

"From NAFLD to MASLD: impact of the new nomenclature"
A. Gastaldelli ; Cardiometabolic Risk Lab., Institute of Clinical Physiology, CNR, Pisa, Italy.
1:35 PM-2:00 PM 25m

Presentation details

"NAFLD and the diabetologist: how to screen it?"
C. Caussy ; Hospices Civils de Lyon, Lyon, France.
2:00 PM-2:30 PM 30m

Presentation details

"Genetically validated targets to treat fatty liver disease"
S. Romeo ; Dept of Molecular and Clinical Medicine, The Wallenberg Laboratory, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
2:30 PM-3:00 PM 30m

Panel discussion: 3:00 PM-3:30 PM 30m